News | May 12, 2026
Shareholders approve J.B. Pharma merger with Torrent Pharma
Proposed amalgamation now awaits NCLT approval; shareholders to receive 51 Torrent Pharma shares for every 100 JB Pharma shares held
Proposed amalgamation now awaits NCLT approval; shareholders to receive 51 Torrent Pharma shares for every 100 JB Pharma shares held
Both ordinary resolutions sail through with over 99.6% votes in favour, strengthening leadership continuity at the drugmaker
Pfizer recommends that shareholders do not tender their shares in response to Tutanota’s offer
Dr Severin Schwan was re-elected as Chairman of the Board with 97.75% of the votes
The company will now seek final approval from NCLT, Mumbai Bench, and upon its receipt, OneSource will proceed to seek listing approvals from the BSE and NSE
The combined entity will enable us to better serve the needs of patients, healthcare professionals and our customers around the world
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally
The shareholders have also ratified the Board’s approval to allot 10 lakhs warrants to the Promoter, Managing Director and CEO, Mark Saldanha at the said price of Rs. 74 per warrant
Expands manufacturing push & locks in major growth deals
Subscribe To Our Newsletter & Stay Updated
